Posts by: Joana Carvalho

News

Two new national surveys on the use of cannabis for the treatment of patients with inflammatory bowel disease (IBD) have been launched in Australia. The anonymous surveys — one ... Read more

April 5, 2019April 5, 2019

EMA Advances Under-the-skin Injection of Entyvio for Crohn’s and Ulcerative Colitis

News

The European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a new subcutaneous (under-the-skin) form of Entyvio (vedolizumab). Entyvio is a biologic agent developed by ... Read more

April 3, 2019April 3, 2019

UK’s NICE Publishes Briefing Supporting PredictImmune Tool for Estimating IBD Flare-up Likelihood

News

The National Institute for Health and Care Excellence (NICE) supports the use of PredictImmune‘s newly launched prognostic tool, PredictSURE IBD, for estimating the likelihoood of disease flare-ups in patients ... Read more

March 27, 2019March 27, 2019

Underweight IBD Patients are More Susceptible to Fatty Liver Disease, Study Suggests

News

Underweight patients with inflammatory bowel disease may be more susceptible to developing non-alcoholic fatty liver disease than those with normal weight, according to a study. The study, “Non-alcoholic fatty ... Read more

March 18, 2019March 18, 2019

Program to Examine Gut Microbiota’s Role in Predicting Response to Therapies

News

uBiome launched a research collaboration program with clinicians from the University of Louisville in Kentucky to investigate the usefulness of the gut microbiome to predict the clinical response of ... Read more

February 18, 2019February 18, 2019

Humira Reduces Early Ulcerative Colitis Features, Trial Analysis Shows

News

AbbVie‘s Humira (adalimumab) reduces early tissue inflammation, rectal bleeding, and stool frequency in patients with ulcerative colitis, according to a post-hoc analysis of two Phase 3 trials. Findings were published ... Read more

February 6, 2019February 6, 2019

Remote Monitoring Offers Little Benefit to IBD Patients, Study Finds

News

Telemedicine monitoring failed to increase inflammatory bowel disease patients’ confidence or motivation to manage their status, compared to standard routine care, a study reported. The study, “Effect of TELEmedicine for Inflammatory ... Read more

January 30, 2019January 30, 2019

Diet and Clear-Mindedness Most Affected Psychosocial Needs in IBD Patients, Study Reports

News

Among 10 different psychosocial needs, diet and a lack of clear-mindedness were the ones most patients with inflammatory bowel disease felt were affected by their disease, a study reports. The ... Read more

December 5, 2018December 5, 2018

Potential IBD Therapy PTG-200 Safe, Well-tolerated in Healthy Volunteers, Phase 1 Results Show

News

PTG-200, being developed by Protagonist Therapeutics in collaboration with Janssen Biotech for the treatment of moderate and severe Crohn’s disease, was found safe and well-tolerated in healthy volunteers, according to top-line results ... Read more